Dillard's, Inc. (DDS) Stock Forecast & Price Target
Dillard's, Inc. · NYSE
$589.12+15.17 (+2.64%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Dillard's, Inc, 0 rate it Buy or better, 1 sit at Hold, and 2 rate it Sell or worse, a moderate sell consensus. Targets span $449.00 to $650.00, a moderate spread. The average target of $521.33 sits 12% below the current $589.12. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $7.94 next quarter toward $34.07 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Sell
Strong Buy00%
Buy00%
Hold133%
Sell267%
Strong Sell00%
Based on 3 analysts giving stock ratings to Dillard's, Inc.
As of Jul, 0 of 3 firms rate DDS a Buy (1 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
DDS EPS & revenue forecast
EPS · NEXT QUARTER
$7.94
Range $7.94 – $7.94 · 1 analysts · -4% YoY
Next period, 1 analysts expect Dillard's, Inc. to earn $7.94 a share (range $7.94 – $7.94), versus $8.29 a year earlier. Full-year consensus is $33.84, growing to $34.07 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.5B – $1.5B · 1 analysts · +0% YoY
Revenue is expected to reach $1.5B (range $1.5B – $1.5B), +0.1% year-over-year. Full-year consensus is $6.6B, rising to $6.7B next year.
Top analysts covering Dillard's, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DDS.
#1
Dana Telsey
Telsey Advisory Group · Rank #368
Hold
$650.00+10.3% to target
Overall win rate
19%
+ Follow
#2
MS
Mauricio Serna
UBS
Sell
$465.00-21.1% to target
Coverage
—
+ Follow
#3
Matthew Boss
JP Morgan
Sell
$449.00-23.8% to target
Coverage
—
+ Follow
DDS stock forecast FAQ
What is DDS's average 12-month price target?+
The 3 analysts with a live target average $521.33 for Dillard's, Inc. over the next 12 months, ranging from a $650.00 high to a $449.00 low.
Is DDS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Sell. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for DDS?+
The Street-high target is $650.00 (Telsey Advisory Group), and the Street-low is $449.00 (JP Morgan). The average of all 3 active targets is $521.33.
How many Wall Street analysts cover DDS?+
3 analysts have an active rating on Dillard's, Inc., and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering DDS?+
Among analysts who currently cover DDS, Dana Telsey of Telsey Advisory Group has the strongest overall Quantellect track record (Rank #368). Their current call is Hold with a $650.00 target.
What is Dillard's, Inc.'s projected EPS for next quarter?+
The consensus estimate is $7.94 per share (range $7.94 – $7.94) across 1 analysts. Full-year EPS is projected at $33.84, rising to $34.07 the following year.
How much revenue is Dillard's, Inc. expected to report next quarter?+
Consensus revenue is $1.5B (range $1.5B – $1.5B). Full-year revenue is projected at $6.6B, growing to $6.7B next year.
Have analysts been upgrading or downgrading DDS lately?+
As of Jul, 0 of 3 firms rate DDS a Buy (1 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DDS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
